Deep brain stimulation for Parkinson's disease - patient selection

Handbook of Clinical Neurology

Volumn 116, Issue , 2013, Pages 97-105

  Pollak, Pierre ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Contraindications; Deep brain stimulation; Indications; Parkinson's disease; Predictive factors; Surgical treatment

Indexed keywords

ARTICLE; BRAIN DEPTH STIMULATION; CONTRAINDICATIONS; HUMAN; INDICATIONS; METHODOLOGY; PARKINSON DISEASE; PATIENT SELECTION; PREDICTIVE FACTORS; SURGERY;

CONTRAINDICATIONS; DEEP BRAIN STIMULATION; INDICATIONS; PARKINSON'S DISEASE; PREDICTIVE FACTORS; SURGICAL TREATMENT;

DEEP BRAIN STIMULATION; HUMANS; PARKINSON DISEASE; PATIENT SELECTION;

EID: 84885168307     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53497-2.00009-7     Document Type: Chapter

References (76)

1. Alegret M., Junque C., Valldeoriola F., et al. Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch Neurol 2001, 58:1223-1227.
2. Ardouin C., Pillon B., Peiffer E., et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999, 46:217-223.
3. Arnulf I., Bejjani B.P., Garma L., et al. Effect of low and high frequency thalamic stimulation on sleep in patients with Parkinson's disease and essential tremor. J Sleep Res 2000, 9:55-62.
4. Arnulf I., Bejjani B.P., Garma L., et al. Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 2000, 55:1732-1734.
5. Bronstein J.M., Tagliati M., Alterman R.L., et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011, 68:165.
6. Burchiel K.J., Anderson V.C., Favre J., et al. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery 1999, 45:1375-1382.
7. Burkhard P.R., Vingerhoets F.J., Berney A., et al. Suicide after successful deep brain stimulation for movement disorders. Neurology 2004, 63:2170-2172.
8. Chahine L.M., Ahmed A., Sun Z. Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures. Parkinsonism Relat Disord 2011, 17:208-211.
9. Charles P.D., Van Blercom N., Krack P., et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002, 59:932-934.
10. Dellapina E., Ory-Magne F., Regragui W., et al. Effect of subthalamic deep brain stimulation on pain in Parkinson's disease. Pain 2012, 153:2267-2273.
11. Derost P.P., Ouchchane L., Morand D., et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?. Neurology 2007, 68:1345-1355.
12. Deuschl G., Schade-Brittinger C., Krack P., et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006, 355:896-908.
13. Dromey C., Kumar R., Lang A.E., et al. An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov Disord 2000, 15:1132-1138.
14. Evans A.H., Strafella A.P., Weintraub D., et al. Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord 2009, 24:1561-1570.
15. Ferraye M.U., Debu B., Fraix V., et al. Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease. Neurology 2008, 70:1431-1437.
16. Ferraye M.U., Debu B., Fraix V., et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010, 133:205-214.
17. Fields J.A., Troster A.I. Cognitive outcomes after deep brain stimulation for Parkinson's disease: a review of initial studies and recommendations for future research. Brain Cogn 2000, 42:268-293.
18. Follett K.A., Weaver F.M., Stern M., et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010, 362:2077-2091.
19. Fraix V., Pollak P., Moro E., et al. Subthalamic nucleus stimulation in tremor dominant parkinsonian patients with previous thalamic surgery. J Neurol Neurosurg Psychiatry 2005, 76:246-248.
20. Fraix V., Houeto J.L., Lagrange C., et al. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006, 77:443-449.
21. Funkiewiez A., Ardouin C., Caputo E., et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004, 75:834-839.
22. Gentil M., Pinto S., Pollak P., et al. Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian dysarthria. Brain Lang 2003, 85:190-196.
23. Ghika J., Ghika-Schmid F., Fankhauser H., et al. Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature. J Neurosurg 1999, 91:313-321.
24. Gorgulho A., De Salles A.A., Frighetto L., et al. Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. J Neurosurg 2005, 102:888-896.
25. Herzog J., Pogarell O., Pinsker M.O., et al. Deep brain stimulation in Parkinson's disease following fetal nigral transplantation. Mov Disord 2008, 23:1293-1296.
26. Herzog J., Weiss P.H., Assmus A., et al. Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation. Brain 2008, 131:132-145.
27. Houeto J.L., Mesnage V., Malle L., et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002, 72:701-707.
28. Hu X., Jiang X., Zhou X., et al. Avoidance and management of surgical and hardware-related complications of deep brain stimulation. Stereotact Funct Neurosurg 2010, 88:296-303.
29. Krack P., Batir A., Van Blercom N., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003, 349:1925-1934.
30. Lang A.E., Houeto J.L., Krack P., et al. Deep brain stimulation: preoperative issues. Mov Disord 2006, 21:S171-S196.
31. Lengerer S., Kipping J., Rommel N., et al. Deep-brain-stimulation does not impair deglutition in Parkinson's disease. Parkinsonism Relat Disord 2012, 18:847-853.
32. Lhommee E., Klinger H., Thobois S., et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. Brain 2012, 135:1463-1477.
33. Lim A.S., Moro E., Lozano A.M., et al. Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons. Ann Neurol 2009, 66:110-114.
34. Limousin P., Pollak P., Hoffmann D., et al. Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord 1996, 11:231-235.
35. Limousin P., Krack P., Pollak P., et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998, 339:1105-1111.
36. Lopiano L., Rizzone M., Perozzo P., et al. Deep brain stimulation of the subthalamic nucleus: selection of patients and clinical results. Neurol Sci 2001, 22:67-68.
37. Ludwig J., Remien P., Guballa C., et al. Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007, 78:742-745.
38. Lyons K.E., Pahwa R. Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease. J Neurosurg 2006, 104:502-505.
39. Mallet L., Mesnage V., Houeto J.L., et al. Compulsions, Parkinson's disease, and stimulation. Lancet 2002, 360:1302-1304.
40. Merola A., Zibetti M., Angrisano S., et al. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain 2011, 134:2074-2084.
41. Mogilner A.Y., Sterio D., Rezai A.R., et al. Subthalamic nucleus stimulation in patients with a prior pallidotomy. J Neurosurg 2002, 96:660-665.
42. Montaurier C., Morio B., Bannier S., et al. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. Brain 2007, 130:1808-1818.
43. Moro E., Esselink R.A., Van Blercom N., et al. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with previous unilateral pallidotomy and thalamotomy. Mov Disord 2000, 15:753-755.
44. Moro E., Esselink R.J., Benabid A.L., et al. Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation. Brain 2002, 125:2408-2417.
45. Moro E., Allert N., Eleopra R., et al. A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease. J Neurol 2009, 256:83-88.
46. Moro E., Hamani C., Poon Y.Y., et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 2010, 133:215-224.
47. Okun M.S., Tagliati M., Pourfar M., et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005, 62:1250-1255.
48. Okun M.S., Fernandez H.H., Wu S.S., et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009, 65:586-595.
49. Ory-Magne F., Brefel-Courbon C., Simonetta-Moreau M., et al. Does ageing influence deep brain stimulation outcomes in Parkinson's disease?. Mov Disord 2007, 22:1457-1463.
50. Oyama G., Rodriguez R.L., Jones J.D., et al. Selection of deep brain stimulation candidates in private neurology practices: referral may be simpler than a computerized triage system. Neuromodulation 2012, 15:246-250.
51. Rouaud T., Dondaine T., Drapier S., et al. Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation. Mov Disord 2010, 25:1839-1846.
52. Russmann H., Ghika J., Villemure J.G., et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology 2004, 63:1952-1954.
53. Saint-Cyr J.A., Trepanier L.L., Kumar R., et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000, 123:2091-2108.
54. Sansur C.A., Frysinger R.C., Pouratian N., et al. Incidence of symptomatic hemorrhage after stereotactic electrode placement. J Neurosurg 2007, 107:998-1003.
55. Sauleau P., Leray E., Rouaud T., et al. Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease. Mov Disord 2009, 24:2149-2155.
56. Schuepbach W.M., Rau J., Knudsen K., et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013, 368:610-622.
57. Stemper B., Beric A., Welsch G., et al. Deep brain stimulation improves orthostatic regulation of patients with Parkinson disease. Neurology 2006, 67:1781-1785.
58. Thobois S., Lhommee E., Klinger H., et al. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain 2013, 136:1568-1577.
59. Tripoliti E., Zrinzo L., Martinez-Torres I., et al. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov Disord 2008, 23:2377-2383.
60. Tripoliti E., Zrinzo L., Martinez-Torres I., et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology 2011, 76:80-86.
61. Tsai S.T., Lin S.H., Chou Y.C., et al. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects. Stereotact Funct Neurosurg 2009, 87:241-248.
62. van Nuenen B.F., Esselink R.A., Munneke M., et al. Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease. Mov Disord 2008, 23:2404-2406.
63. Vesper J., Haak S., Ostertag C., et al. Subthalamic nucleus deep brain stimulation in elderly patients - analysis of outcome and complications. BMC Neurol 2007, 7:7.
64. Vingerhoets G., van der Linden C., Lannoo E., et al. Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999, 66:297-304.
65. Visser J.E., Allum J.H., Carpenter M.G., et al. Subthalamic nucleus stimulation and levodopa-resistant postural instability in Parkinson's disease. J Neurol 2008, 255:205-210.
66. Volkmann J., Albanese A., Antonini A., et al. Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review. J Neurol 2013, [Epub ahead of print].
67. Voon V., Kubu C., Krack P., et al. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006, 21:S305-S327.
68. Voon V., Krack P., Lang A.E., et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008, 131:2720-2728.
69. Weaver F.M., Follett K., Stern M., et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009, 301:63-73.
70. Weintraub D., Burn D.J. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011, 26:1022-1031.
71. Welter M.L., Houeto J.L., Tezenas du Montcel S., et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002, 125:575-583.
72. Williams A., Gill S., Varma T., et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010, 9:581-591.
73. Witjas T., Kaphan E., Regis J., et al. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 2007, 22:1729-1734.
74. Witt K., Daniels C., Reiff J., et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008, 7:605-614.
75. Witt K., Daniels C., Krack P., et al. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease. J Neurol Sci 2011, 310:261-266.
76. Zaidel A., Bergman H., Ritov Y., et al. Levodopa and subthalamic deep brain stimulation responses are not congruent. Mov Disord 2010, 25:2379-2386.